Tommaso Schepis

Università Cattolica del Sacro Cuore

Papers

1

Total Citations

49

H-Index

1

About

Tommaso Schepis is at the forefront of advancing precision medicine in one of oncology’s most formidable challenges: pancreatic cancer. His research centers on the intersection of early diagnosis, innovative therapeutic strategies, and personalized care for this devastating disease. In his landmark 2023 paper, “State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine,” which has already garnered 49 citations, Schepis provides a comprehensive analysis of the current clinical landscape and emerging technologies. He critically examines the persistent barriers to early detection—a key factor behind the disease’s high mortality—while spotlighting promising breakthroughs in targeted therapies, biomarker-driven treatment, and multimodal care. Schepis’s work is distinguished by its forward-looking synthesis, bridging the gap between today’s standard practices and tomorrow’s possibilities. By mapping a clear trajectory toward more individualized, effective interventions, he is helping to reshape the conversation around pancreatic cancer management. His contributions are essential reading for clinicians and researchers committed to translating scientific innovation into tangible survival gains for patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine
49 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Università Cattolica del Sacro Cuore

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago